These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 9450813)

  • 21. Effects of cytokines on platelet production from blood and marrow CD34+ cells.
    Norol F; Vitrat N; Cramer E; Guichard J; Burstein SA; Vainchenker W; Debili N
    Blood; 1998 Feb; 91(3):830-43. PubMed ID: 9446643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombopoietin: biology and clinical potentials.
    Miyazaki H; Kato T
    Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood.
    Schipper LF; Brand A; Reniers N; Melief CJ; Willemze R; Fibbe WE
    Exp Hematol; 2003 Apr; 31(4):324-30. PubMed ID: 12691920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo effects of pegylated recombinant human megakaryocyte growth and development factor on hematopoiesis in normal mice.
    Kabaya K; Akahori H; Shibuya K; Nitta Y; Ida M; Kusaka M; Kato T; Miyazaki H
    Stem Cells; 1996 Nov; 14(6):651-60. PubMed ID: 8948023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombocytopenia with absent radii: frequency of marrow megakaryocyte progenitors, proliferative characteristics, and megakaryocyte growth and development factor responsiveness.
    al-Jefri AH; Dror Y; Bussel JB; Freedman MH
    Pediatr Hematol Oncol; 2000 Jun; 17(4):299-306. PubMed ID: 10845228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressive effects of TNF-alpha, TGF-beta1, and chemokines on megakaryocytic colony formation in CD34+ cells derived from umbilical cord blood compared with mobilized peripheral blood and bone marrow.
    Lu L; Wang LS; Cooper RJ; Liu HJ; Turner K; Weich N; Broxmeyer HE
    J Hematother Stem Cell Res; 2000 Apr; 9(2):195-204. PubMed ID: 10813532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of megakaryocyte growth and development factor (thrombopoietin) effects on blast cell and megakaryocyte growth in myelodysplasia.
    Fontenay-Roupie M; Dupont JM; Picard F; Fichelson S; Botella A; Melle J; Guesnu M; Casadevall N; Dreyfus F; Bouscary D
    Leuk Res; 1998 Jun; 22(6):527-35. PubMed ID: 9678719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L.
    Taksin AL; Couedic JP; Dusanter-Fourt I; Massé A; Giraudier S; Katz A; Wendling F; Vainchenker W; Casadevall N; Debili N
    Blood; 1999 Jan; 93(1):125-39. PubMed ID: 9864154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors.
    Debili N; Wendling F; Katz A; Guichard J; Breton-Gorius J; Hunt P; Vainchenker W
    Blood; 1995 Oct; 86(7):2516-25. PubMed ID: 7545460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin.
    Hagiwara T; Kodama I; Horie K; Kato T; Miyazaki H
    Exp Hematol; 1998 Mar; 26(3):228-35. PubMed ID: 9502619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
    Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
    Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mobilization of primitive haemopoietic progenitor cells and stem cells with long-term repopulating ability into peripheral blood in mice by pegylated recombinant human megakaryocyte growth and development factor.
    Torii Y; Nitta Y; Akahori H; Tawara T; Kuwaki T; Ogami K; Kato T; Miyazaki H
    Br J Haematol; 1998 Dec; 103(4):1172-80. PubMed ID: 9886338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basic fibroblast growth factor promotes the proliferation of human megakaryocyte progenitor cells.
    Bruno E; Cooper RJ; Wilson EL; Gabrilove JL; Hoffman R
    Blood; 1993 Jul; 82(2):430-5. PubMed ID: 8329701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
    Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
    Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE; Erickson-Miller CL; Murphy MJ
    Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further examination of the effects of recombinant cytokines on the proliferation of human megakaryocyte progenitor cells.
    Bruno E; Cooper RJ; Briddell RA; Hoffman R
    Blood; 1991 Jun; 77(11):2339-46. PubMed ID: 1710149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome.
    Letestu R; Vitrat N; Massé A; Le Couedic JP; Lazar V; Rameau P; Wendling F; Vuillier J; Boutard P; Plouvier E; Plasse M; Favier R; Vainchenker W; Debili N
    Blood; 2000 Mar; 95(5):1633-41. PubMed ID: 10688818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.